Jan Frystyk
Jan Frystyk
Professor in Endocrinology, Odense University Hospital
Bekræftet mail på rsyd.dk
Titel
Citeret af
Citeret af
År
Circulating levels of IGF-1 directly regulate bone growth and density
S Yakar, CJ Rosen, WG Beamer, CL Ackert-Bicknell, Y Wu, JL Liu, GT Ooi, ...
The Journal of clinical investigation 110 (6), 771-781, 2002
10312002
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
C Kistorp, J Faber, S Galatius, F Gustafsson, J Frystyk, A Flyvbjerg, ...
Circulation 112 (12), 1756-1762, 2005
6892005
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women
MN Harvie, M Pegington, MP Mattson, J Frystyk, B Dillon, G Evans, ...
International journal of obesity 35 (5), 714-727, 2011
6782011
Obesity and cancer risk: the role of the insulin–IGF axis
AG Renehan, J Frystyk, A Flyvbjerg
Trends in Endocrinology & Metabolism 17 (8), 328-336, 2006
4982006
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity
S Yakar, JL Liu, AM Fernandez, Y Wu, AV Schally, J Frystyk, ...
Diabetes 50 (5), 1110-1118, 2001
4202001
Free insulin-like growth factors in human obesity
J Frystyk, E Vestbo, C Skjaerbaek, CE Mogensen, H Ørskov
Metabolism 44, 37-44, 1995
3781995
Free insulin-like growth factors–measurements and relationships to growth hormone secretion and glucose homeostasis
J Frystyk
Growth Hormone & IGF Research 14 (5), 337-375, 2004
3672004
Free insulin-like growth factors (IGF-I and IGF-II) in human serum
J Frystyk, C Skjærbæk, B Dinesen, H Ørskov
FEBS letters 348 (2), 185-191, 1994
3541994
Circulating levels of free insulin‐like growth factors in obese subjects: the impact of type 2 diabetes
J Frystyk, C Skjaerbaek, E Vestbo, S Fisker, H Ørskov
Diabetes/metabolism research and reviews 15 (5), 314-322, 1999
3241999
The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism
A Bojesen, K Kristensen, NH Birkebaek, J Fedder, L Mosekilde, P Bennett, ...
Diabetes care 29 (7), 1591-1598, 2006
2922006
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.
J Frystyk, B Dinesen, H Orskov
Growth regulation 5 (4), 169-176, 1995
2891995
Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men
J Frystyk, C Berne, L Berglund, K Jensevik, A Flyvbjerg, B Zethelius
The Journal of Clinical Endocrinology & Metabolism 92 (2), 571-576, 2007
2822007
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
J Frystyk, L Tarnow, TK Hansen, HH Parving, A Flyvbjerg
Diabetologia 48 (9), 1911-1918, 2005
2442005
Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I …
M Bidlingmaier, N Friedrich, RT Emeny, J Spranger, OD Wolthers, ...
The Journal of Clinical Endocrinology & Metabolism 99 (5), 1712-1721, 2014
2402014
Whey and casein labeled with l-[1-13C]leucine and muscle protein synthesis: effect of resistance exercise and protein ingestion
S Reitelseder, J Agergaard, S Doessing, IC Helmark, P Lund, ...
American Journal of Physiology-Endocrinology and Metabolism 300 (1), E231-E242, 2011
2052011
Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist
JOL Jørgensen, U Feldt-Rasmussen, J Frystyk, JW Chen, LØ Kristensen, ...
The Journal of Clinical Endocrinology & Metabolism 90 (10), 5627-5631, 2005
1912005
The current status of IGF-I assays–a 2009 update
J Frystyk, P Freda, DR Clemmons
Growth hormone & IGF research 20 (1), 8-18, 2010
1802010
A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum
JW Chen, T Ledet, H Ørskov, N Jessen, S Lund, J Whittaker, P De Meyts, ...
American Journal of Physiology-Endocrinology and Metabolism 284 (6), E1149-E1155, 2003
1792003
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects
U Espelund, TK Hansen, K Højlund, H Beck-Nielsen, JT Clausen, ...
The Journal of Clinical Endocrinology & Metabolism 90 (2), 741-746, 2005
1752005
Serum adiponectin is increased in type 1 diabetic patients with nephropathy
M Saraheimo, C Forsblom, J Fagerudd, AM Teppo, ...
Diabetes care 28 (6), 1410-1414, 2005
1702005
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20